Malta vs Switzerland: Hepatitis B surface antigen (HBsAg) prevalence
Malta
0.0%
in 2024
Switzerland
0.0%
in 2024
Malta rank
132nd
Switzerland rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Malta
- Switzerland
How they compare
Malta currently reports 0.0% against 0.0% in Switzerland, a difference of 0.0%.
Across all 10 years both countries report, Switzerland has been ahead every year.
Malta ranks 132nd and Switzerland ranks 132nd of 194 countries.
Head to head by decade
| Decade | Malta | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Malta or Switzerland?
- Malta, at 0.0% against 0.0% in Switzerland as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Malta and Switzerland?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Switzerland?
- 10 years are reported by both, from 2015 to 2024.
- How do Malta and Switzerland rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Malta ranks 132nd and Switzerland ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.